Diagnostic performances of normalized FDG-PET parameters in predicting treatment response < progression-free survival after bone marrow transplantation in patients with multiple myeloma

被引：0
|
作者：
Ripani, D. [1 ]
Caldarella, C. [2 ,3 ]
Za, T. [4 ]
Pizzuto, D. [1 ]
Rossi, E. [4 ]
De Stefano, V. [4 ]
Giordano, A. [1 ]
机构：
[1] Univ Cattolica Sacro Cuore A Gemelli, Inst Nucl Med, Rome, Italy
[2] Policlin A Gemelli, Nucl Med Unit, Rome, Italy
[3] Policlin A Gemelli, PET CT Ctr, Rome, Italy
[4] Univ Cattolica Sacro Cuore A Gemelli, Hematol Serv, Rome, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-346
引用
收藏
页码：S243 / S243
页数：1
相关论文
共 50 条
  • [31] Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma
    Rajkumar, SV
    Fonseca, R
    Witzig, TE
    Gertz, MA
    Greipp, PR
    LEUKEMIA, 1999, 13 (03) : 469 - 472
  • [32] Relationship of bone scan index and progression-free survival after docetaxel treatment for CRPC patients with bone metastases.
    Mizokami, Atsushi
    Izumi, Kouji
    Ueno, Satoru
    Kadono, Yoshifumi
    Wakabayashi, Hiroshi
    Nakajima, Kenichi
    Namiki, Mikio
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [33] FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma
    Mikhaeel, NG
    Hutchings, M
    Fields, PA
    O'Doherty, MJ
    Timothy, AR
    ANNALS OF ONCOLOGY, 2005, 16 (09) : 1514 - 1523
  • [34] Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma
    Maiolino, Angelo
    Hungria, Vania T. M.
    Garnica, Marcia
    Oliveira-Duarte, Gislaine
    Oliveira, Luciana C. O.
    Mercante, Daniel R.
    Miranda, Eliana C.
    Quero, Adriana A.
    Peres, Ana L. M.
    Barros, Jose C.
    Tanaka, Paola
    Magalhaes, Roberto P.
    Rego, Eduardo M.
    Lorand-Metze, Irene
    Lima, Carmen S. P.
    Renault, Ilana Z.
    Braggio, Esteban
    Chiattone, Carlos
    Nucci, Marcio
    de Souza, Carmino A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (10) : 948 - 952
  • [35] Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma
    Kroeger, N.
    Zabelina, T.
    Berger, J.
    Duske, H.
    Klyuchnikov, E.
    Binder, T.
    Stuebig, T.
    Hilde-Brandt, Y.
    Atanackovic, D.
    Alchalby, H.
    Ayuk, F.
    Zander, A. R.
    Bacher, U.
    Eiermann, T.
    LEUKEMIA, 2011, 25 (10) : 1657 - 1661
  • [36] Longitudinal FDG-PET Revealed Regional Functional Heterogeneity of Bone Marrow, Site-Dependent Response to Treatment and Correlation with Hematological Parameters
    Yagi, Masashi
    Froelich, Jerry
    Arentsen, Luke
    Shanley, Ryan
    Ghebre, Rahel
    Yee, Douglas
    Hui, Susanta
    JOURNAL OF CANCER, 2015, 6 (06): : 531 - 537
  • [37] Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma
    N Kröger
    T Zabelina
    J Berger
    H Duske
    E Klyuchnikov
    T Binder
    T Stübig
    Y Hilde-brandt
    D Atanackovic
    H Alchalby
    F Ayuk
    A R Zander
    U Bacher
    T Eiermann
    Leukemia, 2011, 25 : 1657 - 1661
  • [38] FDG-PET/CT versus contrast enhanced CT for prediction of progression-free and disease-specific survival in stage IV breast cancer patients
    Riedl, Christopher
    Pinker, Katja
    Ong, Leonard
    Jochelson, Maxine S.
    Ulaner, Gary
    McArthur, Heather L.
    Dickler, Maura N.
    Weber, Wolfgang
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [39] The relationship between immunohistochemical parameters and bone marrow fibrosis and bone marrow 18F-FDG uptake in multiple myeloma patients undergoing PET/CT examination
    Oner, A. O.
    Ozdemir, C.
    Yavasoglu, F.
    Senol, Y.
    Adsiz, S. Naz
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (05): : 289 - 295
  • [40] ANALYSIS OF THE PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN ELDERLY PATIENTS (65 YEARS OLD) WITH MULTIPLE MYELOMA PATIENTS ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION.
    Cejalvo, M. J.
    Rubio, L.
    Romero, S.
    Legarda, M.
    Jimenez, M.
    Perla, A.
    Jarque, I
    Ribas, P.
    Arnao, M.
    Andreu, R.
    Dominguez, E.
    De la Rubia, J.
    HAEMATOLOGICA, 2018, 103 : 22 - 23
12345